The COMCID Study Raises New Questions in Dementia Research
National Cerebral and Cardiovascular Center
The COMCID study is Japan’s first multicenter investigator-initiated clinical trial involving patients with mild cognitive impairment
Brain Disorders
Novel Blood Biomarker Identifies Parkinsonian Diseases Early On
Lund University
DOPA decarboxylase was found elevated many years before individuals developed Parkinson’s symptoms
New Roles of Genes Driving Parkinson’s Onset Discovered
Northwestern University
Scientists report that damage starts much earlier than the death of dopamine neurons
Latest Study Reveals Novel Therapeutic Approach for PTSD
Louisiana State University Health Sciences Center
HCN plasticity may have a direct impact on memory formation and can explored to find treatments for PTSD, memory loss
Plasma Test Screens for Alzheimer’s with Very High Accuracy
University of Gothenburg
The new test employs a two-step workflow to accurately identify or exclude brain amyloidosis in patients with MCI
New Blood Biomarker Aids Early Detection of Parkinson’s
Duke Health
Blood test accurately detects certain genetic mutations in the mitochondrial DNA of patients with Parkinson’s
Alzheimer's Blood Tests May Soon Be Referred by GPs
Amsterdam University Medical Centers
New guidelines ascertain the precision and applicability of biomarkers-based Alzheimer’s testing
Tau-Based Biomarker Tracks Alzheimer’s Progression
Washington University in St. Louis
Novel marker found in cerebrospinal fluid also could speed development of Alzheimer’s drugs
Genetic Markers Exacerbating MS Severity Identified
University of Cambridge
Discovery opens the door to treatments for multiple sclerosis-associated long-term disability
New, Simple Blood Test to Diagnose De Vivo Disease
Institut Du Cerveau (Paris Brain Institute)
If used at an early stage, METAglut1 can accurately identify 80 percent of patients with Glut1 deficiency syndrome